Human Platelet Lysate Market

Human Platelet Lysate Market is valued at USD 47.5 Million in 2018 and expected to reach USD 62.1 Million by 2025 with the CAGR of 3.9% over the forecast period.

Human platelet lysate market report is segmented on the basis of product type, application, end-user, and region & country level. Based upon product type, human platelet lysate market is classified into heparin-free platelet lysate and platelet lysate with heparin. On the basis application, the market is classified into a cell therapy, regenerative medicine, stem cell culture and others. On the basis of end-user, the market is classified into biopharmaceutical & pharmaceutical companies, contract research organizations, academic research institutes, and others.

Human Platelet Lysate Market Analysis

Rise in the funding for research and development activities and increased number of research centers, development of novel product innovation, and improving staff clinical efficiency are some of the major driving factors contributing in the human platelet lysate market growth and is expected to do the same over the forecast period. Additionally, rising awareness regarding blood donation and increasing adoption of progressive collection of blood and advanced technology especially observed in the developing regions are expected to derive the growth of human platelet lysate market. Moreover, a large number of population is willingly donating blood in most of the emerging regions is expected to boost the human platelet lysate products demand.

Human platelet lysate is considered to be a suitable alternative to fetal bovine serum as a growth supplement for in-vitro cell culture, which is expected to be adopted for various therapeutic applications in the coming future. Furthermore, human platelet lysate has successfully developed in the field of cell manufacturing for the development of cell-based therapeutics. Moreover, the increasing animal-free serum media demand is estimated to derive the market growth of the human platelet lysate over the forecast period. Rising investment for life science based researches is expected to boost the number of various projects in the research field.

Human Platelet Lysate Market Key Players

The major players operating in the Human Platelet Lysate market are

• Merck Co.
• Mill Creek Life Sciences
• Cook Medical (Cook Regentec)
• AventaCell BioMedical
• STEMCELL Technologies Inc
• Macopharma SA
• Compass Biomedical, Inc
• PL BioScience GmbH
• Trinova Biochem GmbH
• and Others.

Human Platelet Lysate Market Segmentation

By Product Type

• Heparin-free Platelet Lysate
• Platelet Lysate with Heparin

By Application

• Cell Therapy
• Regenerative Medicine
• Stem Cell Culture
• Others

By End-User

• Biopharmaceutical & Pharmaceutical Companies
• Contract Research Organizations
• Academic Research Institutes
• Others

By Regional & Country Level:

North America

• U.S.
• Canada

Europe

• Germany
• France
• U.K.
• Italy
• Spain
• Sweden
• Netherland
• Turkey
• Switzerland
• Belgium
• Rest of Europe

Asia-Pacific

• South Korea
• Japan
• China
• India
• Australia
• Philippines
• Singapore
• Malaysia
• Thailand
• Indonesia
• Rest Of APAC
• Latin America
• Mexico
• Colombia
• Brazil
• Argentina
• Peru
• Rest of South America

The Middle East and Africa

• Saudi Arabia
• UAE
• Egypt
• South Africa
• Rest Of MEA

Rising Demand and Popularity in the Research Field and Among the Healthcare Professionals are expected drive the Growth of this Market

Based on the end-user, academic & research institutes of the human platelet lysate market holds maximum market share because a large number of clinical research and R&D activities are performed in the academic & research institutes. The rising human platelet lysate demand and popularity in the research field and among the healthcare professionals are expected to boost the human platelet lysate market growth. From last few years, the human platelet lysate market has attained a tremendous market growth due to a large number of the population donating blood, which has increased the demand for human platelet lysate. However, the presence of potential competitors in this human platelet lysate market is projected to limit the market growth. Moreover, the need for resources and longtime duration required to understand the research process and specific indication by the researchers to modify and develop the novel product is expected to limit the market growth. Also, competitive pricing pressure is one of the major factors hampering the global market.

North America is the most Prominent Market for the Human Platelet Lysate

Geographically, human platelet lysate market report is segmented into North America, Europe, Asia-Pacific and Rest of the World. The human platelet lysate market in the North America region dominates the global market, followed by Europe, due to a large number of research and development activities in the region, mainly observed in the biopharmaceutical and stem cell field. Moreover, advanced healthcare infrastructure and government healthcare spending are some of the main reason for the growth of the market in the region. The human platelet lysate market in the Asia Pacific region is expected to show moderate growth due to emerging healthcare infrastructure and increasing healthcare spending by the government in the region.

Report Analysis	Details
Historical data	2015 - 2017
Forecast Period	2018 - 2025
Market Size in 2018:	USD 47.5 Million
Base year considered	2017
Forecast Period CAGR %:	3.9%
Market Size Expected in 2025:	USD 62.1 Million
Tables, Charts & Figures:	175
Pages	200
Arthroscopic Burs & Procedures Companies	Merck Co., Mill Creek Life Sciences, Cook Medical (Cook Regentec), AventaCell BioMedical, STEMCELL Technologies Inc, Macopharma SA, Compass Biomedical, Inc, PL BioScience GmbH, Trinova Biochem GmbH
Segments Covered	By Product Type, By Application, By End-User
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa